Last analyzed: May 28, 2026 (Q2 FY26)
Pharmaceuticals
$9.21
Market Cap
$41M
P/E Ratio
18.48
Revenue Rank
Rank 4
Margin Rank
Rank 3
Discover more ways to research and analyze Indian stocks